Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 2
2012 8
2013 15
2014 16
2015 6
2016 4
2017 8
2018 5
2019 8
2020 17
2021 17
2022 15
2023 13
2024 10
2025 5
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

131 results

Results by year

Filters applied: . Clear all
Page 1
Nephroprotective Effects of Silymarin: A Systematic Review and Meta-Analysis.
Frounchi N, Mahmoodpoor F, Zakavi SS, Eyvazova K, Yagubova S, Ardalan M, Ahmadian E, Gareev I, Beylerli O, Roumiantsev S. Frounchi N, et al. Among authors: ardalan m. Biochemistry (Mosc). 2025 Aug;90(8):1140-1152. doi: 10.1134/S0006297925600565. Biochemistry (Mosc). 2025. PMID: 40886393
Associations of renal sinus fat with metabolic parameters, abdominal visceral adipose tissue, metabolic syndrome, fructose intake, and blood pressure control in obese individuals with hypertension: a cross-sectional study.
Anvarifard P, Anbari M, Naemi Kermanshahi M, Ostadrahimi A, Aliasgharzadeh S, Ardalan M. Anvarifard P, et al. Among authors: ardalan m. J Nutr Sci. 2024 Dec 16;13:e94. doi: 10.1017/jns.2024.84. eCollection 2024. J Nutr Sci. 2024. PMID: 39703900 Free PMC article.
Effectiveness of edaravone in preventing contrast-induced nephropathy in high-risk patients undergoing coronary angiography: A randomized, double-blind trial.
Esmailnejad A, Zununi Vahed S, Hejazian SM, Aslanabadi N, Lotfollahhi Gharakhanlu H, Saraei M, Ahmadzadehpournaky A, Ardalan K, Ardalan M, Ghaffari Bavil S. Esmailnejad A, et al. Among authors: ardalan m. Pharmacol Res Perspect. 2024 Aug;12(4):e1228. doi: 10.1002/prp2.1228. Pharmacol Res Perspect. 2024. PMID: 38956898 Free PMC article. Clinical Trial.
131 results